Member Info for lignumvitae

In fact I would go so far as to say that, in my humble opinion, this is one of the best risk/reward small company stocks in the market at the present time.

Nice solid, reassuring AGM statement. Exactly what is required from an emerging junior pharm company. Alkindi & Chronocort will drive this company in the short & medium term. The testosterone breakthrough could well add considerable bulk in the longer term. In my opinion this is a buy & hold - a potential star amongt the wasteland of many of its peers.

PCI is like a precocious child whose parents forever gaze on admirably as it continues to develop. This board is moribund but it will not remain so for long. The upcoming launch of PCA Pal Digital means that PCI now has a complete offering across all platforms. The AGM statement is encouraging. PCI is capitalised at a mere £12.5m. Comprehensive, effective & growing payment platforms are a valuable commodity. Potential investors should do their own research & consider getting aboard for the ride.

Trouble here is that the Open Offer was only some 10% tken up. Accordingly instead of the Gross £7.2 million raise planned it is now only some £5.7m gross. It was stated at the time of the announcement that further funds would be required at end 2020 "or sooner". That timetable is now likely to be brought forward. So good news is required and fast. Otherwise this may be another great british technology success down the plughole.

That is true Puggley but those placees would have to be the ultimate short-termists to dump their newly acquired shares at current levels. My point, essentially, is that holders who can ignore current sentiment & concentrate on the science [and be patient, which, i accept, is a quality notably lacking on these boards] has a good chance of reaping significant rewards.

Taking a mining prospect from greenfield to production is an extremely complex process with many potential pitfalls along the way - a simple fact lost on many of the posters here. We are fortunate to have a CEO with the application & core competencies of DA. Any journey has a start point - a progression & an end point. We are getting ever closer to the end point. Today's announcement contains crucial & positive updates which PI's should welcome. Any holders who no longer have faith would be best avised to sell & move on.

Well, in my very humble opinion there is no logic & the logical conclusion to be drawn from this lack of logic is that the current share price is a bargain.

Before the fundraising announcement the shares traded at 40p with a market cap of some £25m. Following the fundraising what is different - [1] They have an extra £7.6m in the bank & [2] The market cap is £18.5m. The science is unchanged. Find the logic in that if you can?

Well, this morning the SP touched 2.9p. That is bang in line with the Optiva target in their research note of Oct 2018. So, as this more of a company now than then & commodity price fundamentals have moved significantly in the company's favour then in my opinion around 3p represents good value.

DS has stated that the most likely acquirer of Eurasia wil be Russian. Principally because they are best placed to understand the mining & legislative codes &, most particularly the Sovier era resources methodoligies. Of those contenders it seems to me that the most likely is Norilsk Nickel. It is the global leader in Palladium, it has acreages adjacent to EUA, it has refining capacity close to EUA & it has a market cap of some $44 billion. If it were to consider EUA as an attractive add-on then an offer of say $500m would be a fleabite. My gut feeling is for an exit valuation of between 5p & 10p although i am quite willing to be proven wrong on the upside. What we really need as PI's is the same quality of information as potential acquirers will receive when they conduct their due doligence.

Today's RNS represents a very solid update. Potential for significant gains for the patient holder.

Thanks CB1984 - I have made 1 single post on Faron in the last 30 days. You have made 310! Think i am allowed my opinion. No agenda whatsoever - merely my assessment of the state of play.

When the company says that it knows of "no operational or corporate reason for the share price spike" i think it means exactly what it says. When it says that it is funded through to early 2020 [ie just weeks away & that it has increased its available unissued share capital then that means something. Look at C4X trying to get a share issue away at close to 40p & having to accept 15p. In my humble opinion those driving this price rise should make sure that they have their safety belts fully secured.

The post by Jarv55 - Friday 23:10 provides a link to a Johnson Matthey detailed assessment & Q&A session on PGM market fundamentals & 10 year forecasts. This is a must read for any current & prospective investor in Eurasia. Nobody can doubt the depth & expertise of JM & this will enable PI's to "put meat onto the bone".

Volatility will be the order of the day but, with the price still below Optiva Securities October 2018 risk adjusted DCF price target of 2.8p it is still too soon to sell. Much has happened since 2018, both on a micro & macro basis - not least the Montechundra Flanks application which could well imply a quantum leap in reserves. IMO 5p is a medium term target although potential acquirers due diligence will undoubtedly take time.

To speculate on a take out value for Eurasia simply invites ridicule & the potential of a good dollop of egg on face. Nonetheless i think that it could be considerably in excess of where we are now & we may well witness a competitive bidding situation. Potential of 5p + ?

When i saw today's RNS first thing & still blurry eyed, i thought it said Remote were to launch in ASDA. Ye God's, i thought, "Has it really come to this?". Quick reset of the retina & i got it right. And this is a good RNS - a truly positive technical achievement now marketed. Hopefuly, from here, the only way will be up. I believe that the senior management, heavily committed by virtue of their own capital investments in RMS share capital, will want the 0.4p placing to represent the nadir in terms of share price. Every chance of a steady appreciation from here & a multibagger over time for the patient long term holder. And a chance of existing holders recovering a decent chunk of past losses.

All i can say is that the market is suffering from a Split Personality disorder currently where all good news is treated as bad news. Horizonte is a major success story in the writing.

This RNS reads exceptionally well & is another key building block in the development of a major mining company. Of course finance has to be arranged but HZM have demonstrated a clear competence & purpose so far. Whether finance is via a JV [for which i feel certain there will be a queue of willing participants] or JV + take-off arrangements + loan capital + equity remains to be seen but, with a NPV of north of $2BN the investment case is clear. I anticipate a continuation of the share price trajectory.

Sain - if you wish to support your arguements then i would suggest that you avoid Telegraph articles which are selective at best.